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Mastitis is a serious medical condition of dairy cattle. Here, we evaluated whether 
the degree of virulence of mastitis pathogens in a mouse model can be linked to the 
inflammatory response that they provoke. Clinical isolates of Staphylococcus aureus 
(S. aureus) (strain 556 and 392) and Escherichia coli (E. coli ) (676 and 127), and lab-
oratory control strains [8325-4 (S. aureus) and MG1655 (E. coli )], were injected i.p. 
into mice, followed by the assessment of clinical scores and inflammatory parameters. 
As judged by clinical scoring, E. coli 127 exhibited the largest degree of virulence among 
the strains. All bacterial strains induced neutrophil recruitment. However, whereas E. coli 
127 induced high peritoneal levels of CXCL1, G-CSF, and CCL2, strikingly lower levels 
of these were induced by the less virulent bacterial strains. High concentrations of these 
compounds were also seen in blood samples taken from animals infected with E. coli 
127, suggesting systemic inflammation. Moreover, the levels of CXCL1 and G-CSF, 
both in the peritoneal fluid and in plasma, correlated with clinical score. Together, these 
findings suggest that highly virulent clinical mastitis isolates produce a distinct cytokine 
profile that shows a close correlation with the severity of the bacterial infection.
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inTrODUcTiOn
Mastitis is the most costly disease in the dairy industry worldwide, incurring economic losses in 
terms of reduced milk yield, poorer milk quality, and treatment costs (1, 2). Mastitis is defined 
as an inflammation of the mammary gland, typically the response to an intramammary infection 
(3, 4). A mastitis case is categorized as either clinical or subclinical. Cows with clinical mastitis 
present visually recognizable symptoms, such as milk abnormalities and visible changes in the udder. 
Rapidly developing cases are termed acute clinical mastitis. Subclinical mastitis is marked by the 
absence of macroscopically visual symptoms, though milk abnormalities or udder changes may 
occur transiently in a minority of cases. Subclinical cases that persist for at least 2 months are termed 
chronic. Intramammary infections are typically of bacterial origin and the responsible pathogens are 
broadly categorized as either contagious (spread between udder quarters or cows) or environmental 
(opportunistic pathogens) (5, 6). Staphylococci, streptococci, and coliform bacteria constitute the 
majority of etiological mastitis agents (7, 8).
The immune response toward an intramammary infection in cows is greatly influenced by 
the species of the invading bacterium. Escherichia coli (E. coli) commonly causes rapid and 
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powerful immune responses (i.e., acute clinical mastitis), whereas 
Staphylococcus aureus (S. aureus) infections are associated with 
chronic responses (3). The course of the disease is also influenced 
by the strain and bacterial virulence factor, as well as by host and 
environmental factors. In the case of E. coli, it has been shown 
that strains possessing or having upregulated expression of 
factors that enable adhesion, invasion, motility (CheA, Tsr, and 
Tar), and iron acquisition (iroN and sitA) are more likely to cause 
persistent rather than transient intramammary infections (9–11). 
Cows infected with more common S. aureus genotypes experi-
enced faster resolution of the inflammatory response than cows 
infected with less common genotypes (12), possibly because the 
less common genotypes possessed virulence factors enabling per-
sistent infections. Other studies have found that certain genes are 
more common in isolates derived from persistent infection. For 
example, pyrogenic toxin superantigens (PTSAg), enterotoxin-
encoding genes (sed and sej), and a penicillin resistance gene 
(blaZ) were more common in persistent strains (13, 14).
The objective of the current study was to differentiate the 
virulence of a set of acute clinical mastitis isolates using a mouse 
infection model. Non-mammary mouse models have previously 
been used to test the immune response toward mastitis-causing 
bacterial strains, in particular with the aim of defining novel vac-
cination strategies for mastitis (15–18). However, such models 
have not been extensively used to evaluate the inflammatory 
response toward mastitis pathogens. The current study used an 
acute intraperitoneal infection model. S. aureus and E. coli were 
selected by virtue of being common mastitis pathogens (8) and 
for representing the two mastitis pathogen classes – contagious 
(S. aureus) and environmental (E. coli). We demonstrate strain-
dependent variations in virulence in the mouse model, with 
highly virulent E. coli inducing a defined set of inflammatory 
compounds including G-CSF and CXCL1. Moreover, the levels of 
these compounds correlated significantly with clinical outcome, 
suggesting the possibility to further evaluate G-CSF and CXCL1 
as therapeutic targets, therapeutics, or biomarkers in mastitis.
MaTerials anD MeThODs
Mice
Female B6JBOM (C57BL/6) mice (11–17  weeks old) were 
purchased from Taconic. After arrival, the mice were allowed a 
1-month period of acclimatization prior to use. The mice were 
moved to an infection laboratory unit 4 days prior to the start 
of an experiment. During the entire period, the mice were fed 
rodent chow and water ad  libitum. The animals had access to 
enrichment in the form of paper and paper houses. All animal 
experiments were approved by the local ethical committee 
(Uppsala Djurförsöksetiska Nämnd; no C85/14) and were per-
formed in accordance with relevant guidelines and regulations.
Bacterial strains
The clinical mastitis isolates 556 (S. aureus), 392 (S. aureus), 676 
(E. coli), and 127 (E. coli) were obtained from the collection at the 
Swedish National Veterinary Institute (SVA). These strains were 
originally isolated from Swedish dairy cows during a national 
survey (8). Samples were only taken from lactating cows with 
acute clinical mastitis that had not undergone treatment with 
antimicrobials during the previous 30  days, had macroscopic 
changes in the milk in at least one udder quarter, had no pre-
vious record of clinical mastitis during the current lactation 
period, and a somatic cell count at the latest monthly milking of 
<200,000 cells/ml.
As controls for the clinical isolates, we used laboratory strains 
of S. aureus (8325-4) and E. coli (MG1655). The S. aureus strain 
8325-4 (19) was obtained from the collection at the Department of 
Microbiology at the Swedish University of Agricultural Sciences. 
The E. coli strain MG1655 was a kind gift from Diarmaid Hughes 
(Department of Medical Biochemistry and Microbiology, 
Uppsala University).
genotyping
DNA was extracted from E. coli and S. aureus colony material 
collected from horse blood agar plates, using the DNeasy Blood 
& Tissue Kit (Qiagen, Hilden, Germany), according to the manu-
facturer’s instructions. Genotyping was performed using DNA 
microarrays. The Identibac S. aureus Genotyping System (Alere, 
Jena, Germany) was used to genotype the S. aureus isolates. The 
system detects 333 S. aureus genes and gene variants relevant 
for typing as well as resistance and virulence attributes. E. coli 
isolates were characterized using the Identibac Ec System (Alere), 
detecting 124 E. coli virulence genes and gene variants as well 
as control genes. The assays were performed according to the 
manufacturer’s instructions. Hybridization results were detected 
by an ArrayMate Reader (Alere), and signals were registered as 
positive, ambiguous, or negative for each gene or gene variant.
Bacterial cultures
Bacterial strains were streaked onto horse blood agar (S. aureus) 
(SVA, Uppsala, Sweden) or nutrient agar plates (E. coli) (Oxoid, 
Basingstoke, UK). Irrespective of species, the plates were incu-
bated at 37°C for 24  h, after which colonies were picked and 
used to inoculate 20 ml of Tryptic Soy Broth (TSB; BD, Franklin 
Lakes, NJ, USA). Following incubation at 37°C for 16–17  h, 
200 μl of overnight culture was transferred to 20 ml fresh TSB 
and incubated at 37°C until the OD600 reached 0.5. In preparation 
for injection, bacteria were washed twice in PBS (SVA; taken to 
room temperature) and finally resuspended in a volume of fresh 
TSB yielding a 1:1 dilution.
generation Time
The generation time for each strain was determined from the 
increase in OD600 during the exponential phase. Briefly, the strains 
were incubated in TSB at 37°C, and the OD600 was measured every 
30th minute until entry into the stationary phase. The assay was 
performed in triplicates.
In vivo infection & clinical scoring
Mice were injected intraperitoneally with 100 μl TSB medium 
containing bacteria (~2 × 108 CFU of E. coli or ~5 × 108 CFU of 
S. aureus). Body weight was monitored prior to injection. After 
24 h, the general condition of the mice was assessed by clinical 
scoring (Table 1), followed by weighing. The mice were subse-
quently euthanized, and samples were taken in the following 
TaBle 1 | clinical scoring.
clinical scorea criteria
1 Active, responsive, and no signs of any illness
2 Slower in reaction to stimuli, but otherwise active and healthy
3 Slow and lethargic, but still active
4 Inactive but still responsive to stimuli, albeit slowly
5 Inactive and non-responsive to any stimuli
Additional scores 
of 0.5 were added 
cumulatively based 
on the presence of:
• Ocular changes [dry encrusted eye(s), pus covered 
eyes or a grayish opaque film]
• Intestinal disturbances (loose fecal pellets)
• Shivering
aNote that the maximal score is 6.5 (main clinical scores 1–5 + additional scores of 0.5). 83
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FigUre 1 | generation times of bacterial strains. Generation times for 
the Staphylococcus aureus strains (8325-4, 556, 392) and the Escherichia 
coli strains (MG1655, 676, 127) were determined from the exponential phase 
measured in TSB and at OD600.
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order: blood via the eye, peritoneal lavage with 5 ml cold PBS, 
mesenteric lymph nodes, and spleens. The lymph nodes and 
spleens were weighed. Presence of E. coli in the blood was deter-
mined by streaking a 10 μl aliquot of blood onto MacConkey agar 
(Oxoid). The colony-forming unit count (CFU) in the peritoneal 
lavage fluid was determined by plating a 100 μl aliquot onto horse 
blood agar (S. aureus) or nutrient agar/MacConkey agar (E. coli). 
The cells in peritoneal lavage fluid were counted. Cytospins were 
prepared from an aliquot of the peritoneal cells and were stained 
with May-Grünwald/Giemsa, followed by differential counting. 
Finally, the remaining cells in the peritoneal lavage fluid were 
pelleted by centrifugation; the supernatant was collected and 
stored at −20°C.
cytokine arrays & elisas
Cytokine levels in the peritoneal lavage fluid were determined 
using RayBio® Mouse Inflammation Array C1 (RayBiotech, Inc., 
Norcross, GA, USA), according to the manufacturer’s instruc-
tions. Equal volumes of peritoneal lavage fluid from five mice 
were pooled to give the volume required for one membrane. The 
integrated density of the upregulated cytokines was quantified 
using ImageJ software and was normalized using the positive 
controls on each filter. The density of each spot was then compared 
with negative controls (peritoneal lavage fluid from non-infected 
animals); results are given as % density in comparison with the 
negative control. ELISAs were performed on peritoneal lavage 
fluid and blood plasma for CCL2 (Ready-SET-Go; eBioscience), 
CXCL1, and G-CSF (PeproTech), according to the manufactur-
ers’ instructions.
statistical analysis
Data are shown as means ±  SD. Statistical analyses were per-
formed by using GraphPad Prism 6.0 (GraphPad Software), using 
one-way ANOVA without matching and Fisher’s LSD post  hoc 
test. Correlation analysis was performed using non-parametric 
Spearman correlation with a two-tailed P-value.
resUlTs
genotype and growth characteristics of 
Mastitis Pathogens
The clinical isolates used in this study were all derived from the 
milk of cows suffering from acute clinical mastitis. The clinical 
isolates were genotyped (see Tables S1 and S2 in Supplementary 
Material). As shown in Table S1 in Supplementary Material, the 
S. aureus strains 556 and 392 clinical isolates shared a high degree 
of similarity in terms of virulence factors. However, they differed 
in terms of enterotoxins, with strain 392 harboring genes encod-
ing enterotoxins, whereas S. aureus 556 did not. The E. coli clinical 
isolate 676 carried genes encoding cytotoxic necrotizing factor 
(cnf), cytolethal distending toxin (cdt), as well as the F17 fimbriae. 
This trio of virulence factors encoded on the same plasmid (pVir) 
is characteristic of type 2 necrotoxic E. coli (NTEC-2), which 
has been reported to frequently colonize the gastrointestinal 
tract of healthy ruminants [reviewed by De Rycke et  al. (20)], 
but also been shown to cause both diarrhea and invasion of the 
blood stream in newborn calves (21), dependent only on factors 
encoded on the Vir plasmid (22). The E. coli 127 isolate lacked all 
virulence factors represented in the microarray system (Table S2 
in Supplementary Material).
The bacterial growth rate has previously been suggested to 
influence mastitis strain virulence (3). In order to assess whether 
differences in growth rate of these bacterial strains could influ-
ence their virulence, the generation time for each strain was 
determined in TSB at 37°C. As shown in Figure 1, all strains of 
each species had virtually identical generation times, approxi-
mately 30 min for S. aureus and 22 min for E. coli.
Mice infected with E. coli 127 exhibit 
severe clinical symptoms
To investigate differences in clinical outcome for the selected 
strains, a mouse intraperitoneal infection model was used. 
Clinical outcome was assessed by measuring weight loss and 
by scoring clinical signs 24  h after infection. The mesenteric 
lymph nodes and spleens were also collected and weighed. As 
shown in Figure 2A, the weight loss of the mice in response to 
the different bacterial strains was relatively similar, with averages 
ranging from 6–12% over 24 h. In addition to monitoring clinical 
outcome by weight changes, we also implemented a clinical score 
system ranging from 1 to 5, where 1 represented animals with 
normal activity and 5 represented inactive, unresponsive animals 
83
25
-4 55
6
39
2
MG
16
55 67
6
12
7
0
5
10
15
20
W
ei
gh
tL
os
s 
(%
)
A
*
83
25
-4 55
6
39
2
MG
16
55 67
6
12
7
0
2
4
6
C
lin
ic
al
Sc
or
e
****
B
*
Co
ntr
ol
83
25
-4 55
6
39
2
MG
16
55 67
6
12
7
0.000
0.005
0.010
0.015
W
ei
gh
t(
g)
*
C Lymph  Nodes
Co
ntr
ol
83
25
-4 55
6
39
2
MG
16
55 67
6
12
7
0.00
0.02
0.04
0.06
0.08
0.10
W
ei
gh
t(
g)
*
*
D Spleens
FigUre 2 | effect of intraperitoneal bacterial infection on weight loss and clinical outcome. Mice were injected intraperitoneally with Staphylococcus 
aureus (8325-4, 556, 392) or Escherichia coli (MG1655, 676, 127). (a) After 24 h, weight loss of mice was monitored. (B) Severity of infection was monitored using 
clinical scoring as described in Table 1. (c,D) The weights of mesenteric lymph nodes (c) and spleens (D) were assessed. Data represent mean ± SD. *p < 0.05; 
****p < 0.0001 (n = 4–10).
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(Table 1). Additional scores of 0.5 were added cumulatively for 
the presence of other clinical signs (ocular changes, intestinal dis-
turbances, and shivering; see Table 1). As displayed in Figure 2B, 
the E. coli strain 127 caused the highest increase in clinical score 
out of all the bacterial strains tested. Moreover, mice infected 
with S. aureus 556 developed higher clinical scores than animals 
infected with the control S. aureus strain (8325-4).
None of the assessed bacterial strains caused a significant 
increase in the weight of the mesenteric lymph nodes in com-
parison with non-infected controls (Figure  2C). However, we 
noted that lymph nodes taken from mice infected with the E. coli 
strain 676 weighed less than those from mice infected with E. 
coli MG1655 (Figure 2C). Infection with either of the S. aureus 
strains did not cause any significant effects on spleen weight 
(Figure 2D). In contrast, infection with E. coli MG1655 or E. coli 
676 caused small, yet significant, increase in the weight of the 
spleens. Notably though, infection with the E. coli strain 127 did 
not result in increased spleen weight (Figure 2D).
To monitor any differences in bacterial persistence in  vivo, 
peritoneal lavage was performed on the mice after euthanasia, 
followed by plating the fluid onto agar plates and quantification of 
the CFU. Mice infected with the clinical E. coli isolate 127 exhib-
ited a poor bacterial clearance compared with the laboratory 
strain MG1655 (Figure 3). In particular, the strain 127 persisted 
at very high numbers after 24  h in the mice. In contrast, the 
clinical S. aureus isolates 556 and 392 did not yield higher CFU 
numbers than did the laboratory strain 8325-4.
Cows afflicted with acute coliform mastitis have previously 
been shown to frequently develop bacteremia originating from 
the mammary infection (23, 24). To determine whether any 
of the E. coli strains assessed here could spread outside the 
peritoneal cavity, blood from infected mice was streaked onto 
MacConkey agar and incubated at 37°C for 24 h. As displayed 
in Table 2, E. coli strain 127 was present in these blood streaks, 
while MG1655 and 676 were not.
Mastitis Pathogens cause leukocyte 
recruitment into the Peritoneal cavity
Next, we investigated whether the difference in clinical signs in 
response to the various bacterial strains tested could be associ-
ated with differences in inflammatory parameters. To this end, 
peritoneal cell populations from the infected mice were collected, 
followed by the assessment of total cell counts and differential 
cell counting after May-Grünwald/Giemsa staining of cytospin 
slides. As seen in Figure  4A, infection with S. aureus 8325-4, 
S. aureus 556, and E. coli MG1655 caused a significant increase 
TaBle 2 | Bacteremia after Escherichia coli infection.
strain Bacteria detected in blood
MG1655 0/5
676 0/5
127 5/5
Isolate 127 but not 676 or the laboratory strain MG1655 causes bacteremia. Mice were 
injected intraperitoneally with Escherichia coli (MG1655, 676, 127). After 24 h mice 
were euthanized. Blood samples were assessed for bacteremia.
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FigUre 3 | Presence of bacteria in the peritoneal cavities of 
infected mice. Mice were injected intraperitoneally with Staphylococcus 
aureus (8325-4, 556, 392) or Escherichia coli (MG1655, 676, 127). After 
24 h, the presence of persistent bacteria (colony-forming units; CFU) in the 
peritoneal lavage fluid was determined. Data represent mean ± SD. 
****p < 0.0001 (n = 4–10).
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of the total cell counts in the peritoneal cavity. In contrast, there 
was only a trend of increased total cell counts after infection with 
S. aureus 392 and E. coli 676, and no effect on total cell counts of 
the peritoneal cavity were seen after infection with E. coli 127. In 
response to all of the tested bacterial strains, a significant influx 
of neutrophils into the peritoneal cavity was seen (Figure 4D). In 
contrast, the numbers of peritoneal mast cells (Figure 4B) or mac-
rophages (Figure 4E) were not affected by any of the bacteria, and 
there was no increase in the lymphocyte population in response 
to any of the bacterial strains, except for a modest increase in 
lymphocyte numbers in response to S. aureus 556 (Figure 4F). 
Eosinophil populations were only marginally affected by infec-
tion with the bacterial strains used (Figure 4C), although it was 
noted that infection with S. aureus 392 and E. coli 127 caused a 
slight, yet significant, increase in peritoneal eosinophil numbers 
(Figure 4C).
E. coli strain 127 causes a local and a 
systemic cytokine response
In order to further investigate if the difference in clinical outcome 
of the different bacterial strains could be related to inflamma-
tory parameters, we assessed differences in the cytokine output 
in response to the respective bacteria. We used an inflamma-
tory cytokine array as a screening method for this purpose. As 
shown in Figure S1 in Supplementary Material (shown for the 
E. coli strains) and Figure 5 (quantification by densitometry of 
data from all bacteria), several inflammatory cytokines/com-
pounds were induced to varying extents by the various bacterial 
strains. However, the most striking induction of cytokines was 
seen after infection with E. coli 127. In particular, there was a 
dramatic increase in the levels G-CSF, IL-6, CXCL1, and CCL2 
in response to this bacterial strain, whereas much lower levels 
of these compounds were seen in the peritoneal cavity of mice 
infected with any of the other bacterial strains. To confirm these 
findings by independent methodology, we used ELISA. As shown 
in Figures  6A–C, ELISA measurements confirmed a robust 
induction of CXCL1, G-CSF, and CCL2 in the peritoneal cavity 
of mice infected with E. coli 127 in comparison with infection 
with any of the other bacteria. However, a trend of upregulation 
of these compounds was also seen in response to S. aureus 556. 
Notably, there was a strong positive correlation between the bac-
terial counts in the peritoneal lavage fluid (CFU) and the levels 
of levels of CXCL1, G-CSF, and CCL2 (Figures 7A,C,E). As mice 
infected with E. coli 127 displayed the most severe clinical signs 
of infection, we additionally asked whether the levels of these 
inflammatory compounds showed a correlation with clinical 
score. Indeed, there was a significant positive correlation between 
the clinical score and the levels of CXCL1, G-CSF, and CCL2, 
respectively (Figures 7B,D,F).
Next, we assessed if the induction of inflammatory cytokines 
in the peritoneal cavity also was reflected by corresponding 
increases in blood plasma samples, i.e., reflecting a systemic 
inflammatory response. Indeed, infection with E. coli 127 caused 
a dramatic increase in the levels of G-CSF and CXCL1 in plasma, 
whereas none of the other bacterial strains tested caused signifi-
cant upregulation of these compounds (Figures 6D,E). However, 
a tendency toward upregulated G-CSF and CXCL1 plasma levels 
was seen after infection with S. aureus 556 (Figures 6D,E). To 
further evaluate the association between the levels of G-CSF 
and CXCL1 with clinical outcome, we assessed whether levels 
of plasma G-CSF and CXCL1 showed a correlation with clini-
cal score. As seen in Figures 7G,H, the plasma levels of both of 
these compounds were positively correlated with the clinical 
score. Together, these findings suggest that the high virulence of 
E. coli 127 is associated with a dramatic induction of a specific 
set of inflammatory compounds, such as CXCL1 and G-CSF, and 
that the levels of these compounds are correlated with clinical 
outcome and bacterial burden.
DiscUssiOn
The outcome of bovine mastitis is determined by host (25, 26) 
and pathogen factors (27, 28). It is known that the severity of 
mastitis varies depending on the species of the causative bacteria 
[reviewed in Ref. (3)]. Additionally, particular genes encoding 
virulence factors have been frequently isolated from bacterial 
strains able to cause more severe or persistent intramammary 
infections. Although there is some knowledge regarding the viru-
lence factors that are expressed by common mastitis pathogens 
(see Introduction), there is still only limited knowledge of how 
mastitis pathogens affect the host immune response, a limiting 
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FigUre 4 | effect of bacterial infection on peritoneal leukocyte populations. Mice were injected intraperitoneally with Staphylococcus aureus (8325-4, 556, 
392) or Escherichia coli (MG1655, 676, 127). After 24 h, peritoneal lavage was performed and the (a) number of total cells was quantified; differential counting of 
mast cells (B), eosinophils (c), neutrophils (D), macrophages (e), and lymphocytes (F) was performed after May-Grünwald/Giemsa staining of cytospin slides. Data 
represent mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 (n = 6–10).
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factor for such research efforts being the challenging task of 
performing relevant studies in the bovine species. As an alterna-
tive, it may be possible to address this issue by performing studies 
in rodent models, and, here, we aimed to elucidate how mastitis 
pathogens affect the immune response by using a mouse acute 
intraperitoneal infection model. Although it can be questioned 
whether such mouse non-mammary models give an adequate 
picture of the inflammatory events occurring in mastitis, it should 
be emphasized that non-mammary models have previously been 
used for this purpose and have been suggested to represent useful 
tools for studying mastitis (17, 18, 29, 30).
Among the mastitis pathogens evaluated here, we found that 
the E. coli strain 127 exhibited the highest virulence as judged by 
clinical scoring. The higher virulence of this strain as opposed 
to the less virulent E. coli strains tested was most likely not due 
to a higher growth rate, as shown by analysis of the generation 
times for the different bacterial strains. This finding is, thus, in 
some contrast to earlier studies, where it has been suggested that 
the in  vitro growth rate is predictive of in  vivo virulence (17, 
31). Moreover, E. coli 127 did not induce a more profound effect 
on lymphoid organ weight as compared with the other strains 
tested. It was also apparent that all of the bacterial strains tested 
produced a relatively similar inflammatory response in terms 
of neutrophil recruitment, whereas no significant recruitment 
of monocytes/macrophages or other leukocytes populations 
was observed, indicating that the high virulence of E. coli 127 
is not due to a failure of the host to recruit neutrophils to clear 
the infection. However, E. coli 127 was shown to persist in the 
peritoneal cavity at markedly higher numbers as compared with 
the other bacterial strains tested. This suggests that E. coli 127 has 
FigUre 5 | Presence of cytokines in the peritoneal fluids after bacterial infection. Mice were injected intraperitoneally with Staphylococcus aureus (8325-4, 
556, 392) or Escherichia coli (MG1655, 676, 127). After 24 h, peritoneal lavage was performed. The presence of pro-inflammatory cytokines in peritoneal lavage fluid 
was determined by using an antibody-based array. The figure represents quantification of the cytokine array data by densitometry using ImageJ. Data are given as 
% integrated density in comparison to negative controls (plasma from non-infected animals). Levels of expression correlate with the intensity of red color.
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a higher capability of evading eradication by the host response 
than have the other tested strains. Alternatively, although not 
possessing an intrinsically higher growth rate compared with 
the other E. coli strains, E. coli 127 may be better adapted than 
the other strains to maintain growth in the peritoneal milieu. It 
was also observed that infection with E. coli 127 was associated 
with bacteremia, whereas the other E. coli strains tested did not 
penetrate into the blood. This indicates that infection with E. coli 
127 results in a systemic infection, well in line with the severe 
outcome as judged by clinical scoring. In line with these findings, 
bacteremia is common among cows afflicted with acute coliform 
mastitis (23, 24, 32). Interestingly, E. coli 127 possessed none 
of the virulence genes represented in the microarray system, 
suggesting the involvement of other less obvious virulence or 
survival factors. In contrast, E. coli 676 belongs to the NTEC-2 
pathotype known to be capable of causing bacteremia in cattle 
(21, 22), but was less virulent as judged by clinical scoring in the 
present study.
In order to further investigate the reason(s) behind the dif-
ferential virulence of the bacterial strains tested, we assessed 
the cytokine output induced by the various bacterial strains. 
We, thereby, found that the highly virulent E. coli 127 induced 
a dramatic increase of G-CSF, CXCL1, CCL2, and IL-6, whereas 
the levels of these were low in peritoneal cavities of mice infected 
with any of the other bacterial strains. Importantly, we found high 
levels of such compounds also in the blood plasma, in line with 
a systemic inflammatory response induced by E. coli 127. G-CSF 
is a growth factor that promotes the survival, proliferation, and 
differentiation of neutrophils, as well as enhancing the activity 
of mature neutrophils (33), and we may, thus, envisage that the 
high induction of G-CSF reflects an attempt by the host to cope 
with the bacterial infection by promoting the expansion of the 
neutrophil population. CXCL1 is a chemokine with neutrophil 
attracting properties (34), and the induction of this chemokine 
may, thus, also reflect the need for neutrophil recruitment in 
order to cope with the severe infection caused by E. coli 127 (34). 
In agreement with a role of this chemokine in mastitis, CXCL1 is 
detectable at the protein level in the bovine mammary gland in 
response to intramammary lipoteichoic acid (LTA) infusion (35). 
CCL2 is a chemokine that is chemoattractant for macrophages/
monocytes (36). The induction of this chemokine may, thus, 
suggest a role of macrophages/monocytes in the host response. 
Of note, bovine mammary epithelial cells and mammary tissue 
express CCL2 mRNA in response to LPS stimuli (37, 38), in 
agreement with a link between this chemokine and mastitis. IL-6 
is a powerful, pro-inflammatory cytokine with wide impact on 
the host response against various pathogens (39), and it has been 
shown previously that IL-6 is elevated during mastitis (40). High 
levels of this cytokine may, thus, be expected to accompany a 
severe bacterial infection by mastitis pathogens, such as the one 
caused by E. coli 127.
Altogether, these findings suggest that severe bacterial infec-
tion caused by mastitis pathogens results in a distinct profile of 
induced inflammatory compounds. Most likely, the induction of 
these compounds may represent a response that is protective for 
the host, by promoting the recruitment of neutrophils to the site 
of infection. We may, thus, envisage that treatment of infected 
subjects with the corresponding compounds may represent a 
potential therapeutic approach to limit infection. In line with 
this, attempts to enhance the immune competence of peripar-
turient dairy cows by administrating recombinant G-CSF have 
been shown to increase the numbers and functional properties 
of neutrophils (41, 42).
The basis of the high virulence of E. coli 127 is intrigu-
ing. As judged by our genotyping for the presence of known 
virulence factors, E. coli 127 did not harbor genes coding for 
additional virulence factors in comparison with E. coli 676. 
The high virulence of E. coli 127 is, therefore, most likely due 
to non-characterized virulence factors/mechanisms. However, 
the nature of such factors/mechanisms is at present unknown. 
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Interestingly, these findings are in analogy with the results of 
an extended survey of E. coli milk isolates from bovine mastitis, 
where it was observed that many of the pathogens causing 
acute clinical mastitis lacked well-characterized virulence 
factor genes (K. Artursson et  al., unpublished results). This 
notion is also supported by a recent study from Kempf et  al. 
who demonstrated by using a genomic comparative approach 
that mastitis E. coli isolates lacked well-characterized virulence 
factors (43).
As an alternative to exploiting these findings for therapeutic 
purposes, we foresee the possibility of using our findings for 
diagnostic purposes. Clearly, there is a demand for improved 
tools for diagnosing different grades of mastitis, in particular 
for detection of subclinical mastitis (44). Based on the findings 
obtained in this investigation, high levels of G-CSF and CXCL1 
may accompany severe, systemic bacterial infection, and it is, 
thus, possible that levels of G-CSF and/or CXCL1 may be useful 
diagnostic criteria in mastitis. In agreement with such a notion, 
0 2 4 6 8
0
1
2
3
4
5
6
Log CFU/ml
C
XC
L1
(n
g/
m
l)
r=0.5789
p<0.0001
A
0 1 2 3 4 5 6 7
0
1
2
3
4
5
6
r=0.5504
p<0.0001
Clinical Score
C
XC
L1
(n
g/
m
l)
B
0 2 4 6 8
0
10
20
30
40
50
60
70
80
90
Log CFU/ml
G
-C
SF
(n
g/
m
l)
r=0.8372
p<0.0001
C
0 1 2 3 4 5 6 7
0
10
20
30
40
50
60
70
80
90
r=0.6555
p<0.0001
Clinical Score
G
-C
SF
(n
g/
m
l)
D
0 2 4 6 8
0
5
10
15
20
Log CFU/ml
C
C
L2
(n
g/
m
l)
r=0.8616
p<0.0001
E
0 1 2 3 4 5 6 7
0
5
10
15
20
r=0.7352
p<0.0001
Clinical Score
C
C
L2
(n
g/
m
l)
F
0 1 2 3 4 5 6 7
0
100
200
300
400
500
r=0.6222
p<0.0001
Clinical Score
C
XC
L1
(n
g/
m
l)
G
0 1 2 3 4 5 6 7
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000 r=0.6470
p<0.0001
Clinical Score
G
-C
SF
(n
g/
m
l)
H
Peritoneal Lavage  Fluid Peritoneal Lavage  Fluid
Peritoneal Lavage  Fluid Peritoneal Lavage  Fluid
Peritoneal Lavage  Fluid Peritoneal Lavage  Fluid
Plasma Plasma
FigUre 7 | The levels of g-csF, cXcl1, and ccl2 correlate with clinical outcome and with bacterial burden. Mice were injected intraperitoneally with 
Staphylococcus aureus (8325-4, 556, 392) or Escherichia coli (MG1655, 676, 127). (a,c,e) Correlation between bacterial counts (CFU) and CXCL1 (a), G-CSF (c), 
and CCL2 (e) levels in the peritoneal lavage fluid. (B,D,F) Correlation between clinical score and levels of CXCL1 (B), G-CSF (D), and CCL2 (F) in the peritoneal 
lavage fluid. (g,h) Correlation between clinical score and levels of CXCL1 (g) and G-CSF (h) in plasma.
9
Johnzon et al. Mastitis Pathogens and Cytokines
Frontiers in Immunology | www.frontiersin.org September 2016 | Volume 7 | Article 368
we found that the levels of these compounds correlated sig-
nificantly with severity of infection as judged by clinical scoring. 
However, further studies are needed to clarify whether induction 
of these particular pro-inflammatory factors also accompanies 
bovine mastitis.
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